• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • PROs
    • Menopause Rating Scale
      • Menopause Rating Scale (MRS) – Languages
    • Aging Male Symptoms Scale
      • AMS – properties as an outcome measure
      • AMS – properties as a screening tool
    • Quality of Sexual Function Scale
      • Quality of Sexual Function Scale
    • Short Term Hormone Effect Scale
      • Short Term Hormone Effect Scale
    • Research team
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Publications

Heinemann Lothar A , Do Minh Thai, Strelow Frank, Gerbsch Silvia, Schnitker Jörg, Schneider HPG, The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? Health and Quality of Life Outcome. 2004; 2:67. Doi:10.1186/1477-7525-2-67.
Heinemann Lothar A , Recent results on HRT: Problems encountered by an epidemiologist. Menopause Review. 2004; 9:7-12.
Heinemann Lothar A , Dinger Jürgen, Safety of a new oral contraceptive containing drospirenone Drug Safety. 2004; 27(13):1001-18.
Heinemann Lothar A , WHI-Studie und Million Women Study aus epidemiologischer Sicht. Frauenarzt. 2004; 45 (3):217-22.
Heinemann Lothar A , Saad F, Heinemann Klaas, Do Minh Thai, Can results of the AMS scale predict those of screening scales for androgen deficiency?. Aging Male. 2004; 7:211-18.
Moore C, Huebler D, Zimmermann T, Heinemann Lothar A , Saad F, Do Minh Thai, The AMS scale as outcome measure for treatment of androgen deficiency Eur Urology. 2004; 46:80-7.
Heinemann Klaas, Alexander Ruebig Alexander, Potthoff P, Schneider HPG, Strelow Frank, Heinemann Lothar A , Do Minh Thai, The Menopause Rating Scale: A methodological review. Health and Quality of Life Outcomes. 2004; 2:45 (2 September 2004). 10.1186/1477-7525-2-45.
Potthoff P, Heinemann Lothar A , A household panel as a tool for cost-effective health-related population surveys: validity of the “Healthcare Access Panel”. German Medical Science. 2004; 2:Doc05/20040716/.
Heinemann Lothar A , Saad F, The aging male’s symptoms scale. Schneider HPG (Ed.) Menopause. The state of the art – in research and management. The Parthenon Publishing Group. Boca Raton, London, New York, Washington. 2003; 319-324.
Heinemann Klaas, Thiel C, Lewis Michael, Raff T, Heinemann Lothar A , Benign gynecological tumors: estimated incidence. Results of the German Cohort study on Women’s Health Eur J Obst Gyn Reprod Biol. 2003; 107: 78-80.
Heinemann Lothar A , Lewis Michael, Kuehl-Habich D, Braendle W, Cancer of the uterus and ovary and lifetime history of oral contraceptive use. A German case-control study. Geburth.Frauenheilk. 2003; 63:1018-26.
Heinemann Lothar A , Saad F, Zimmermann T, Novak A, Myon E, Badia X, Potthoff P, T’Sjoen G, Pöllänen P, Goncharow NP, Kim S, Giroudet C, The Aging Males’ Symptoms (AMS) scale: update and compilation of international versions Health and Quality of Life Outcomes. 2003; 1: 15.. 10.1186/1477-7525-1-15.
  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Interim pages omitted …
  • Page 22
  • Go to Next Page »

sidebar

Search our Publications

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Patient Reported Outcomes (PROs)
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2025 ZEG Berlin

Impressum

Website by Laura Yeffeth.